These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10862469

  • 1. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD, Kraĭdashenko OV, Berezin OIe, Oliĭnyk OI.
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [Abstract] [Full Text] [Related]

  • 2. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI, Vakhliaev VD.
    Eksp Klin Farmakol; 1996 Mar; 59(4):18-20. PubMed ID: 9026181
    [Abstract] [Full Text] [Related]

  • 3. [The role of metabolic correction in the combined therapy of middle-aged and elderly patients with ischemic heart disease].
    Kraĭdashenko OV, Berezin AE, Molodan AV.
    Lik Sprava; 1996 Mar; (10-12):114-6. PubMed ID: 9138782
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
    Arushanian EB, Shamliian TA.
    Eksp Klin Farmakol; 1995 Mar; 58(1):31-3. PubMed ID: 7787692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of alpha-1 adrenergic blockade on the clinical course, immune status and blood plasma lipid spectrum in patients with ischemic heart disease].
    Lizogub VG, Chumak AA, Savchenko AV, Pliskevich DA.
    Lik Sprava; 2000 Mar; (3-4):31-4. PubMed ID: 10921255
    [Abstract] [Full Text] [Related]

  • 11. [The clinico-hemodynamic effects of the antioxidant ceruloplasmin in IHD patients].
    Zakirova AN.
    Ter Arkh; 1995 Mar; 67(4):33-5. PubMed ID: 7784970
    [Abstract] [Full Text] [Related]

  • 12. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B, Panja M.
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [Abstract] [Full Text] [Related]

  • 13. [Psychophysiological approaches to assessing patients with painful and painless forms of ischemic heart disease].
    Lipovetskii BM, Reznikova TN, Il'ina GN, Petukhova NV, Stoianov AM.
    Ter Arkh; 1995 Jun; 67(12):8-11. PubMed ID: 8820044
    [Abstract] [Full Text] [Related]

  • 14. [Results of long-term administration of propranolol to patients with ischemic heart disease].
    Bychko MV.
    Lik Sprava; 2003 Jun; (5-6):93-5. PubMed ID: 14618816
    [Abstract] [Full Text] [Related]

  • 15. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB, Upnitskiĭ AA, Sokolov AV, Tishchenkova NF, Karasev AV, Egorova NA.
    Ter Arkh; 1997 Jun; 69(3):61-3. PubMed ID: 9229836
    [No Abstract] [Full Text] [Related]

  • 16. [Pelotherapy in ischemic heart disease].
    Davydova OB, Nikolaeva LF, Nagiev IuK.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1994 Jun; (1):2-6. PubMed ID: 8171844
    [Abstract] [Full Text] [Related]

  • 17. [Angina pectoris. Silent ischemia].
    Tuna JL.
    Acta Med Port; 1997 Apr; 10(4):267-75. PubMed ID: 9341023
    [Abstract] [Full Text] [Related]

  • 18. [The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
    Skibitskiĭ VV.
    Ter Arkh; 1992 Apr; 64(8):25-9. PubMed ID: 1279829
    [No Abstract] [Full Text] [Related]

  • 19. [The preoperative drug correction of disorders in myocardial functional reserve in patients with ischemic heart disease].
    Molodan AV, Salgalov AV, Osaulenko VV, Materukhin AN.
    Klin Khir (1962); 1994 Apr; (5):29-31. PubMed ID: 7807893
    [Abstract] [Full Text] [Related]

  • 20. Anti-anginal effects of partial fatty acid oxidation inhibitors.
    Lam A, Lopaschuk GD.
    Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.